ONDANSETRON hydrochloride, eq. 2mg/ml base, 2ml, amp.

STD DINJONDA4A-

Valid Article

Former Code(s): DINJZNL0118
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
17.2 - Antiemetic medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
2.3 - Medicines for other common symptoms in palliative care
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
A04AA01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

ONDANSETRON

Therapeutic Action

Antiemetic (5HT3-receptor antagonist)

Indications

Prevention and treatment of post-operative nausea and vomiting

Instructions for use

Must be given as slow IV injection.

Ondansetron replaces metoclopramide injectable for post-operative nausea and vomiting and paediatric use.

Precautions for Use

Do not administer in children under 1 month of age.

Storage

Below 25ºC -Protect from sunlight